2013-04-30 19:04:57 UTC

A Message from Drs. David Katzka and Prateek Sharma, Course Directors, 2013 Freston Conference

May 2, 2013

Course directors, David Katzka, MD, and Prateek Sharma, MD, provide insight on how Barrett's esophagus has prompted researchers and clinicians to investigate up-to-date, state-of-the-art consensus guidelines for treating the disease.

Barrett’s esophagus and adenocarcinoma of the esophagus are fields that are exploding with new knowledge. Partly because of the dramatic increase in occurrence of Barrett’s esophagus in the population over the last 20 years, but also due to the multidisciplinary interest that spans many fields and approaches — from the most basic of molecular studies to epidemiology and endoscopy. As a result, Barrett’s esophagus has emerged not just as a disease of gastroenterology but of much of medicine. On the other hand, when a disease covers so many areas, it becomes difficult to keep track of available literature. Understanding all the current nuances and future directions of such a disorder presents challenges as well.

With regards to Barrett’s esophagus, it would take a researcher or clinician an extraordinary amount of time to read months’ worth of literature in this field over a broad range of journals and conferences. In addition, it would be even more difficult to fully grasp all the important concepts, identify key areas of needed exploration or the clinical challenges that need to be addressed and practiced.

For the 2013 James W. Freston Conference, we have assembled internationally renowned leaders in Barrett’s esophagus basic science and clinical research with the intent of promoting open discussion and education on this fascinating esophageal disease. This is an excellent opportunity for investigators to exchange a broad range of information with faculty and other attendees. The conference appeals to all who have an interest in Barrett’s, whether for better care of patients or answering key questions. Faculty and attendees will work together to formulate the most up-to-date, state-of-the-art consensus guidelines in the field of Barrett’s esophagus and esophageal adenocarcinoma. This will depend not only on the expertise of the faculty but will also rely on necessary input from the attendees themselves. As a result, this meeting promises to be exciting, stimulating, broadly educational, social and enjoyable for all who have an interest in Barrett’s esophagus.

To learn more and register today, visit www.gastro.org/barretts

More on Barrett's Esophagus

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

How to Talk with Your Patients About PPIs and Cognitive Decline

Feb. 22, 2018

More information clearing concerns about the use of proton pump inhibitors (PPIs).